CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro.

Wei DaiShuo FangGuanhe CaiJialiang DaiGuotai LinQiurong YeHuilai MiaoMing ChenXiaoyu TanNian-Ping Chen Xiaoguang Liu Mingyi Li

Published in: The Journal of international medical research (2021)

CDKN3 may have a dual role during the development of HCC, and could be used as an independent prognostic factor and therapeutic target for HCC treatment.

Keyphrases

poor prognosis
prognostic factors
long non coding rna
replacement therapy
binding protein
smoking cessation